Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Olema Pharmaceuticals (OLMA) Share-based Compensation (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Share-based Compensation data on record, last reported at $10.1 million in Q1 2026.

  • On a quarterly basis, Share-based Compensation rose 131.8% to $10.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $23.4 million, a 5.92% increase, with the full-year FY2025 number at $17.6 million, down 22.12% from a year prior.
  • Share-based Compensation reached $10.1 million in Q1 2026 per OLMA's latest filing, up from $4.3 million in the prior quarter.
  • Over the last five years, Share-based Compensation for OLMA hit a ceiling of $10.1 million in Q1 2026 and a floor of $4.1 million in Q3 2023.
  • A 5-year average of $5.1 million and a median of $4.7 million in 2025 define the central range for Share-based Compensation.
  • Peak YoY movement for Share-based Compensation: tumbled 32.53% in 2025, then soared 131.8% in 2026.
  • Tracing OLMA's Share-based Compensation over 5 years: stood at $4.9 million in 2022, then decreased by 10.49% to $4.4 million in 2023, then soared by 45.32% to $6.3 million in 2024, then crashed by 32.53% to $4.3 million in 2025, then surged by 137.88% to $10.1 million in 2026.
  • Business Quant data shows Share-based Compensation for OLMA at $10.1 million in Q1 2026, $4.3 million in Q4 2025, and $4.2 million in Q3 2025.